Multidisciplinary Approaches to Understand Cancer Treatment Resistance
The NCI Cancer Target Discovery and Development (CTD2) Network and Cancer Systems Biology Consortium (CSBC) are organizing a virtual, multi-date symposium titled "Multidisciplinary Approaches to Understand Cancer Treatment Resistance". The purpose of the series is to highlight research focused on understanding the mechanisms of cancer therapy resistance and sensitivity using systems-level approaches. The symposium is planned over five days with four scientific themes:
- Approaches to design combination therapies (November 16, 2020)
- Evolutionary biology approaches to understand resistance (November 17, 2020)
- The role of the tumor ecosystem in drug resistance and sensitivity (December 2, 2020)
- Tumor heterogeneity and cell plasticity during therapy (December 16-17, 2020)
Each virtual mini-symposium will be two hours in length (12:00 p.m. ET – 2:00 p.m. ET) and feature five talks from leaders in the fields of cancer biology and systems biology. The first session will kick-off with remarks from Dr. Ned Sharpless at 11:30 a.m. ET. Sli.do-based question collection will be utilized to collect the most pressing questions from the audience. Please join the CTD2 and CSBC for this exciting series.